Blog

Data from the EMPA-REG study were unveiled in Stockholm 6 weeks ago. In more than 7,000 adults with type 2 diabetes (T2D) at high risk for CV events, EMPA-REG OUTCOME met its primary endpoint and demonstrated superiority of JARDIANCE, when added...
  1.   Saturday, 07 November 2015
  2.   General nephrology
  3. 1 Comments
Canada becomes the first country outside Japan to approve JinarcTM (Tolvaptan) for the treatment of ADPKD. This medication, dosed twice daily, is the first of its kind to show a slowing in renal function decline as well as a slowing in kidney enlarge...
  1.   Thursday, 26 February 2015
  2.   General nephrology
  3. 0 Comments
Previously, UKidney News reported a possible link between calcium channel blockers and the development of breast cancer. Data from the Intermountain Medical Center Heart Institute study were presented at the 2014 American Heart Association Scien...
  1.   Wednesday, 26 November 2014
  2.   Hypertension
  3. 0 Comments
Imagining the Dream RCT in nephrology is an important exercise, but not for the reasons you might think. For many, there might be the temptation to devise trials that will pave the way for future enhancements to patient care or to some other exciting...
  1.   Tuesday, 28 January 2014
  2.   General nephrology
  3. 1 Comments
Top-line results of the Symplicity 3 trial were revealed this week, showing that despite being safe, renal denervation was no better than a sham procedure at controlling blood pressure at 6 months. As reported on Medscape:...
  1.   Saturday, 11 January 2014
  2.   Hypertension
  3. 0 Comments
Jordan Weinstein doesn't have any blog post yet.
Unable to load tooltip content.
ukidneyisup